Systemic viral interleukin-10 gene delivery prevents cartilage invasion by human rheumatoid synovial tissue engrafted in SCID mice

被引:0
|
作者
Jorgensen, C [1 ]
Apparailly, F
Canovas, F
Verwaerde, C
Auriault, C
Jacquet, C
Sany, J
机构
[1] Hop Lapeyronie, Serv Immunorhumatol, Montpellier 5, France
[2] INSERM, Montpellier, France
[3] Inst Pasteur, F-59019 Lille, France
来源
ARTHRITIS AND RHEUMATISM | 1999年 / 42卷 / 04期
关键词
D O I
10.1002/1529-0131(199904)42:4<678::AID-ANR10>3.0.CO;2-S
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess the effects of viral interleukin-10 (vIL-10) gene delivery on human rheumatoid synovial tissue. Methods. SCID mice were engrafted subcutaneously with human rheumatoid synovial tissue and homologous cartilage before systemic injection of 109 plaque-forming units of type 5 E1a E1b-deficient nonreplicative adenovirus vector containing the vIL-10 gene under control of the cytomegalovirus promoter (AdvIL-10; n = 10) or a control gene (AdvIL-10mut; n = 7). Three weeks later, the graft was removed for histologic analysis of cartilage invasion by synovial tissue. The number of CD3-positive mononuclear cells was assessed in the synovial tissue by immunohistology. Messenger RNA (mRNA) expression of matrix metalloproteinase 3 (MMP-3), tissue inhibitor of metalloproteinases 1 (TIMP-1), and proinflammatory cytokines was determined by polymerase chain reaction. Results. Systemic vIL-10 gene transfer resulted in high sustained production of vIL-10 protein in SCID mouse sera (mean +/- SD 25 +/- 5 ng/ml on day 40 post vector injection). Moreover, vIL-10 mRNA expression was detected in the synovial tissue 3 weeks after intravenous injection of AdvIL-10, reflecting the gene transfer in the human graft. In animals treated with AdvIL-10, cartilage invasion by rheumatoid synovial tissue was significantly inhibited compared with the control vector (mean +/- SD histologic score 2.5 +/- 0.52 versus 0.75 +/- 0.8; P < 0.0001). The number of T cells infiltrating the synovium and perichondral resorption in the animals treated with AdvIL-10 gene were not significantly modified relative to the control vector. In animals treated with AdvIL-10, the MMP3-TIMP-1 balance was partially restored, independent of the effect on mRNA expression of tumor necrosis factor alpha, IL-1, IL-6, or IL-8. Conclusion. Systemic vIL-10 gene transfer prevented cartilage invasion by synovial tissue engrafted in SCID mice. This model offers the opportunity to study the biologic effects of gene transfer in vivo in rheumatoid synovium.
引用
收藏
页码:678 / 685
页数:8
相关论文
共 50 条
  • [21] Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice
    Wolschek, MF
    Thallinger, C
    Kursa, M
    Rössler, V
    Allen, M
    Lichtenberger, C
    Kircheis, R
    Lucas, T
    Willheim, M
    Reinisch, W
    Gangl, A
    Wagner, E
    Jansen, B
    HEPATOLOGY, 2002, 36 (05) : 1106 - 1114
  • [22] Adenovirus-mediated viral interleukin-10 gene transfer prevents concanavalin A-induced liver injury
    Zhou, Yan-Chun
    Chen, Sui
    Cao, Jun-Jun
    Chen, Shao-Ying
    Xie, Yan-Fei
    Niu, Qing-Xia
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (05) : 398 - 405
  • [23] Vitaxin, a humanized monoclonal antibody, inhibits alphaV/beta3 integrin in human RA synovial tissue engrafted into SCID mice.
    El-Gabalawy, HS
    Hitchon, CA
    Ma, GP
    El-Gabalawy, NC
    Bailey, JL
    White, AM
    Jones, RE
    Lyttle, D
    Davis, LS
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S41 - S41
  • [24] SYNOVIAL TISSUE IMPLANTS FROM PATIENTS WITH RHEUMATOID-ARTHRITIS CAUSE CARTILAGE DESTRUCTION IN KNEE JOINTS OF SCID.BG MICE
    SACK, U
    KUHN, H
    ERMANN, J
    KINNE, RW
    VOGT, S
    JUNGMICHEL, D
    EMMRICH, F
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (01) : 10 - 16
  • [25] Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr - /- Mice
    von der Thüsen, JH
    Kuiper, J
    Fekkes, ML
    de Vos, P
    van Berkel, TJC
    Biessen, EAL
    FASEB JOURNAL, 2001, 15 (12): : 2730 - +
  • [26] Irsogladine Maleate Prevents Colitis in Interleukin-10 Gene-Deficient Mice by Reducing Interleukin-12 and-23 Production
    Nakagawa, Tomoo
    Katsuno, Tatsuro
    Noguchi, Yoshiko
    Mandai, Yasushi
    Yoshihama, Sayuri
    Saito, Keiko
    Maruoka, Daisuke
    Matsumura, Tomoaki
    Arai, Makoto
    Yokosuka, Osamu
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (11) : 1681 - 1688
  • [27] Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice
    PTH Coates
    R Krishnan
    S Kireta
    J Johnston
    GR Russ
    Gene Therapy, 2001, 8 : 1224 - 1233
  • [28] Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice
    Coates, PTH
    Krishnan, R
    Kireta, S
    Johnston, J
    Russ, GR
    GENE THERAPY, 2001, 8 (16) : 1224 - 1233
  • [29] Th2 cytokine injected in rheumatoid synovium implanted in scid mice have a protective effect on human engrafted cartilage and decrease MNC recruitment.
    Jorgensen, C
    Couret, I
    Canovas, F
    Reme, T
    Sany, J
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1682 - 1682
  • [30] Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar–Kyoto rats
    N Higuchi
    H Maruyama
    T Kuroda
    S Kameda
    N Iino
    H Kawachi
    Y Nishikawa
    H Hanawa
    H Tahara
    J Miyazaki
    F Gejyo
    Gene Therapy, 2003, 10 : 1297 - 1310